<DOC>
	<DOCNO>NCT00290420</DOCNO>
	<brief_summary>The purpose study determine , weekly prophylaxis malaria attack treatment , chloroquine , appropriate way protect woman foetus P. vivax malaria infection pregnancy .</brief_summary>
	<brief_title>Prevention P. Vivax Malaria During Pregnancy Bolivia</brief_title>
	<detailed_description>It demonstrate malaria responsible anaemia pregnancy reduces birth weight among newborn . In Bolivia , malaria mostly cause P. vivax . Maternal foetal consequence P. vivax infection poorly investigate , South America . In fact , recommendation protection pregnant woman malaria Bolivia clearly establish . Prophylaxis chloroquine still recommend continent Africa , mainly chloroquine resistance still uncommon P. vivax specie . The alternative way protect woman pregnancy treat malaria attack antenatal visit . For purpose , realize study order ass appropriate way protect woman foetus malaria infection , i.e . weekly prophylaxis mild malaria attack treatment , chloroquine . By realize randomize multicentric clinical trial 800 woman group , compare impact maternal malaria attack incidence rate , proportion mother anaemia , low-birth weight positive parasitaemia pregnancy delivery , weekly prophylaxis mild malaria attack diagnosis treatment . The study undertaken 18 month region Santa Cruz give important information Bolivian Ministry Health establish national recommendation .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Malaria , Vivax</mesh_term>
	<mesh_term>Chloroquine</mesh_term>
	<mesh_term>Chloroquine diphosphate</mesh_term>
	<criteria>Pregnancy 4 36 week gestation Intention deliver maternity clinic Residence near maternity clinic Written inform consent ( parent tutor age &lt; 18 year ) Pregnancy prior 4 week 36 week gestation Allergy chloroquine Clinical sign hepatic renal alteration Inability take drug oral route Presence effective uterine contraction</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>malaria</keyword>
	<keyword>Plasmodium vivax</keyword>
	<keyword>pregnancy</keyword>
	<keyword>chemoprophylaxis</keyword>
</DOC>